Pfizer has abandoned work on a PD-L1-targeting drug that was being tested in patients with various cancers. | Pfizer has ...

TNX-1700 (TFF2-albumin fusion protein) reversed aging-associated gastric inflammation and significantly attenuated tumor progression in aged ...

Patients with operable non-small cell lung cancer (NSCLC) had significantly longer event-free survival (EFS) with ...

Completed enrolment in Phase 2b clinical trial of imaging agent RAD 101 in patients with recurrent brain metastases following earlier announcement of interim data demonstrating concordance with MRI (t ...

Agenus appoints BAP Pharma as exclusive global partner for BOT+BAL access programmes: Lexington, Massachusetts Thursday, April 23, 2026, 16:00 Hrs [IST] Agenus Inc., a leader in i ...

LLY's oncology drugs, led by Verzenio and new launches, are set to support upcoming Q1 results as investor focus broadens ...

Parth Desai, MBBS, MD, discusses how clinicians balance liquid biopsy, tissue testing, and fast-start chemo to personalize ...

SINO BIOPHARMACEUTICAL (01177.HK) announced that Vetricotobat Monoclonal Antibody (CLDN18.2 ADC), a Class 1 innovative drug ...

Former McMinnville Police Sgt. Terry “TJ” Ward died of cancer Saturday, April 18. He was 77. A celebration of his life will be held at 4 p.m. Sunday, May ...

Company execs still have high hopes for the SERD giredestrant, despite a recent trial failure in first-line metastatic breast ...

The presentation is titled “ BBO-11818: an orally bioavailable, highly potent and selective non-covalent pan-KRAS (ON) and (OFF) inhibitor with robust anti-tumor activity in KRAS-mutant preclinical ...